
CAS 1030769-75-5
:Formel:C26H19N5O2S
InChl:InChI=1S/C26H19N5O2S/c32-24-12-8-17-13-18(7-11-20(17)28-24)22-14-34-26(29-22)30-25(33)16-5-9-19(10-6-16)31-15-27-21-3-1-2-4-23(21)31/h1-7,9-11,13-15H,8,12H2,(H,28,32)(H,29,30,33)
InChI Key:DXSMYUKZPWJQFM-UHFFFAOYSA-N
SMILES:C1CC(=O)NC2=C1C=C(C=C2)C3=CSC(=N3)NC(=O)C4=CC=C(C=C4)N5C=NC6=CC=CC=C65
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
4 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
SRI 37892
CAS:SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability.Formel:C26H19N5O2SReinheit:99.93%Farbe und Form:SolidMolekulargewicht:465.5264-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
CAS:Kontrolliertes Produkt4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide (AQBT) is a potent and selective inhibitor of ion channels. AQBT has a high affinity for Na+ currents in the CNS and peripheral nervous system of rats. It is a potent blocker of α7 nicotinic acetylcholine receptors. This compound also inhibits the activity of the neuronal γ amino butyric acid type A receptor (GABAAR).
Formel:C26H19N5O2SReinheit:Min. 95%Molekulargewicht:465.5 g/mol




